Literature DB >> 7502736

Radiosurgery of the metastatic brain tumours with gamma-knife.

Y Kida1, T Kobayashi, T Tanaka.   

Abstract

The results of treatment of metastatic brain tumours by radiosurgery are reported. Twenty cases including lung (11), colon (5), breast (1), ovary (1), liver cancer (1) and malignant melanoma (1) were involved. Seven cases had single and 13 had multiple brain metastases. In total 55 lesions were evaluated after radiosurgery with the gamma-knife. Following localization with MR1 and dose planning, radiosurgery with marginal doses between 12 to 25 Gy (mean 18.9 Gy) was delivered. In the follow-up studies with MRI after 3 months, 29 out of 55 (52.7%) lesions showed significant shrinkage. In contrast 25 showed either no change (17) or central necrosis (8), and one was enlarged. Thus the tumour control at 3 months was 98.2%, and subsequently 96.6% at 6 months. Clinical symptoms and signs were improved in most cases, but were aggravated in four cases either by tumour recurrence or by radiation-induced oedema. Although the tumours treated with radiosurgery were well controlled, tumour recurrence in another sites occurred in 4 case, of which 3 were treated by 2nd radiosurgery with 2 successful tumour control. Complications were generally mild and transient. In summary stereotactic radiosurgery is valuable new treatment not only for solitary metastases, but also for multiple or recurrent ones.

Entities:  

Mesh:

Year:  1995        PMID: 7502736     DOI: 10.1007/978-3-7091-9399-0_18

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  2 in total

1.  Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control.

Authors:  Akifumi Miyakawa; Yuta Shibamoto; Shinya Takemoto; Toru Serizawa; Shinya Otsuka; Tatsuo Hirai
Journal:  Int J Clin Oncol       Date:  2016-11-08       Impact factor: 3.402

2.  Analysis of 2000 cases treated with gamma knife surgery: validating eligibility criteria for a prospective multi-institutional study of stereotactic radiosurgery alone for treatment of patients with 1-10 brain metastases (JLGK0901) in Japan.

Authors:  Toru Serizawa; Yoshinori Higuchi; Osamu Nagano; Yasunori Sato; Masaaki Yamamoto; Junichi Ono; Naokatsu Saeki; Akifumi Miyakawa; Tatsuo Hirai
Journal:  J Radiosurg SBRT       Date:  2012
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.